All Stories

  1. Health Care Costs Associated With Norovirus at the Veterans Health Administration
  2. Shigella Infections in the United States Veterans Health Administration
  3. RSV Genomic Characterization
  4. P-2327. West Nile Virus Disease in the Veterans Health Administration (VHA), 2010-2023
  5. P-2328. Influenza and RSV Surveillance in the US Veterans Health Administration (VHA): 2023-2024 Season
  6. RSV Vaccine Effectiveness
  7. Risk Factors for Extrapulmonary Tuberculosis Among US Veterans, 1990–2022
  8. Clinically Defined Lymphogranuloma Venereum among US Veterans with Human Immunodeficiency Virus, 2016–2023
  9. Mpox in the Veterans Health Administration
  10. 898. Influenza Surveillance in the US Veterans Health Administration (VHA): 2022-2023 Season
  11. 1992. Two Decades of Lyme Disease in the U.S. Veterans Health Administration Detected Via Automated Surveillance Methodology, October 1999 - September 2022
  12. 899. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration (VHA)
  13. 1797. Pneumococcal Vaccination in Veterans 65 years and older with Pneumococcus in the Veterans Health Administration (VHA) since November 2021
  14. Norovirus hospitalizations and mortality in Veterans Health Administration
  15. Coccidioidomycosis (Valley Fever) in the Veterans Health Administration
  16. Trends in Follow-up Testing Among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration, 2013 to 2019
  17. 2220. Trends in Follow-up Testing among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration (VHA), 2013-2019
  18. 1967. Receipt of Influenza Vaccination as Predictor of COVID-19 Vaccination among United States Veterans
  19. Exposure Sources Among Veterans With Elevated Blood Lead Levels, United States, 2015‒2021
  20. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–2019
  21. Association of Secretor Status and Recent Norovirus Infection With Gut Microbiome Diversity Metrics in a Veterans Affairs Population
  22. Public health surveillance in the U.S. Department of Veterans Affairs: evaluation of the Praedico surveillance system
  23. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
  24. 1201. Diphtheria in Veterans Health Administration (VHA), 2000-2021
  25. 227. Epidemiology of bloodstream infections in Veterans Health Administration, 2010-2020
  26. 1444. Influenza Surveillance in the Veterans Health Administration (VHA): 2020-2021 Season
  27. 702. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–19
  28. 98. COVID-19 Vaccine Breakthrough Hospitalizations and Deaths in the Veterans Health Administration
  29. Adapting the Surveillance Platform for Enteric and Respiratory Infectious Organisms at United States Veterans Affairs Medical Centers (SUPERNOVA) for COVID-19 Among Hospitalized Adults: Surveillance Protocol
  30. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
  31. Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020
  32. COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study
  33. COVID-19 Infections Among Healthcare Personnel in the United States Veterans Health Administration, March to August, 2020
  34. Risk for In-Hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020
  35. 1534. Gonorrhea Testing and Ceftriaxone Resistance in the Department of Veterans Affairs (VA), 2010-2019
  36. 1709. Influenza Surveillance in the U.S. Department of Veterans Affairs (VA): 2019-2020 Season
  37. Candida auris in the US Department of Veterans’ Affairs (VA)
  38. Prevalence of Drug-Resistant Mycobacterium tuberculosis in the Veterans Health Administration (VHA)
  39. Lessons Learned From a Decade of Dental Lookback Investigations in the Department of Veterans’ Affairs (VA): 2009–2019
  40. Lack of Evidence of Transmission of Bloodborne Viruses by Improperly Reprocessed Fiberoptic Endoscopes
  41. 1718. Respiratory Syncytial Virus (RSV) Surveillance in the Department of Veterans Affairs (VA), 2010-2018
  42. 397. Respiratory Coinfections with COVID-19 in Veterans Health Administration (VA), 2020
  43. COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study (Preprint)
  44. Incidence, Etiology, and Severity of Acute Gastroenteritis Among Prospectively Enrolled Patients in 4 Veterans Affairs Hospitals and Outpatient Centers, 2016–2018
  45. Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US Populations
  46. 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
  47. 1882. Tuberculosis in the Department of Veterans Affairs: Missed Opportunities for Prevention
  48. 2313. Influenza and Respiratory Syncytial Virus (RSV) Surveillance in the US Department of Veterans Affairs (VA): 2018–2019 Season
  49. 2322. Etiology, Severity of Illness, and Risk Factors for Patients Hospitalized with Acute Gastroenteritis from Multi-Site Veteran’s Affairs (VA) Surveillance, 2016–2018: Results from SUPERNOVA
  50. Acute Hepatitis A Infection and Vaccination in the Veterans Health Administration
  51. Acute Hepatitis A Infections among Veterans in Outbreak States, 2016-2018
  52. Trends in Incidence of Norovirus-associated Acute Gastroenteritis in 4 Veterans Affairs Medical Center Populations in the United States, 2011–2015
  53. Carbon monoxide poisoning surveillance in the Veterans Health Administration, 2010–2017
  54. 1499. Gonorrhea and Chlamydia Infections in the Department of Veterans Affairs (VA), 2013–2017
  55. 2504. Influenza Surveillance and Outbreaks in the US Department of Veterans Affairs (VA): 2017–2018 Season
  56. 1648. Incidence of Norovirus and Rotavirus From Multisite Active Surveillance in Veteran’s Affairs Hospitals, December 2016–February 2018: Results From the SUPERNOVA Network
  57. Zika virus infection in the Veterans Health Administration (VHA), 2015-2016
  58. Influenza infections among U.S. Veterans.
  59. Epidemiologic Review of Veterans Health Administration Patients with Isolation of Nontuberculous Mycobacteria after Cardiopulmonary Bypass Procedures
  60. Enhanced Influenza Surveillance Using Telephone Triage and Electronic Syndromic Surveillance in the Department of Veterans Affairs, 2011-2015
  61. Firearm Injury Encounters in the Veterans Health Administration (VHA), 2010-2015
  62. Carbon Monoxide Poisoning in the Veterans Health Administration, 2010 - 2016
  63. Dengue, Chikungunya & Zika Virus in VA Caribbean HCS, Nov. 2015-Aug. 2016
  64. Comparative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines among Veterans: 2015–2016 and 2016–2017 Seasons
  65. Factors for Hospitalizations and Neurologic Complications in Zika Virus Infection in the Department of Veterans Affairs (VA)
  66. Incidence of Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011–2015
  67. Are current screening protocols for chronic hepatitis B virus infection adequate?
  68. Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014
  69. Improving the Value Proposition of Surveillance Tools: Innovative Uses for VA ESSENCE
  70. Enhancing Biosurveillance Specificity Using PraedicoTM, A Next Generation Application
  71. Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae, Duodenoscopes, and Endoscopic Ultrasonography in the Department of Veterans Affairs
  72. Influenza Surveillance in the Department of Veterans Affairs (VA): 2015–2016 Season
  73. Zika Virus Infection in the Department of Veterans Affairs (VA)
  74. Epidemiologic Review of Department of Veterans Affairs Patients With Isolation of Non-Tuberculous Mycobacteria After Cardiopulmonary Bypass Procedures
  75. Carbapenem-Resistant Enterobacteriaceae and Antimicrobial Usage Within the Veterans Affairs Healthcare System: 2010–2014
  76. Use of Shortened Regimen for the Treatment of Latent Tuberculosis Infection in Patients of the Veterans Affairs Healthcare System, 2012–2015
  77. Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012
  78. Reuse of Insulin Pens Among Multiple Patients at 2 Veterans Affairs Medical Centers
  79. Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011-2012
  80. Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection
  81. Evaluation of PraedicoTM, A Next Generation Big Data Biosurveillance Application
  82. Pertussis Surveillance in Veterans Affairs Medical Centers in Western United States – 2010-2014
  83. Influenza Infection in the Department of Veterans Affairs (VA), 2014–2015
  84. Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae and Duodenoscopes in the Department of Veterans Affairs
  85. Influenza Surveillance in the Department of Veterans Affairs (VA): 2012-2013 Influenza Season
  86. 1292Incidence of norovirus-associated acute gastroenteritis in four Veteran's Affairs Medical Center populations in the United States, 2011-2012
  87. 1064Influenza Infection in the Department of Veterans Affairs (VA): 2013-2014
  88. 1690Opportunities for Improved Detection and Treatment of Latent Tuberculosis Infection Among Veterans — Western United States, January 2010–July 2013
  89. Combining Surveillance Systems: Effective Merging of U.S. Veteran and Military Health Data
  90. Does Antimicrobial Prescription Data Improve Influenza Surveillance in VA?
  91. Coverage and Timeliness of Combined Military and Veteran Surveillance Systems
  92. Enhanced Influenza Surveillance using Telephone Triage Data in the VA ESSENCE Biosurveillance System
  93. Characteristics of Veterans Accessing the Veterans Affairs Telephone Triage Who Have Depression or Suicidal Ideation: Opportunities for Intervention
  94. Localized Cluster Detection Applied to Joint and Separate Military and Veteran Subpopulations
  95. Dengue Surveillance in Veterans Affairs Healthcare Facilities, 2007–2010
  96. Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-term-care facility
  97. Vascular access hemorrhages contribute to deaths among hemodialysis patients
  98. Results from a Large-Scale Epidemiologic Look-Back Investigation of Improperly Reprocessed Endoscopy Equipment
  99. Comparative Assessment of Antimicrobial Usage Measures in the Department of Veterans Affairs
  100. Another type of cluster monitoring: detection of groups of anomalous patient residence locations
  101. Inpatient data: a new frontier in Veterans Affairs biosurveillance and public health monitoring from the electronic health record
  102. Hierarchical filtering of ESSENCE for routine, distributed disease monitoring by the Veterans Health Administration
  103. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks
  104. Enhanced health event detection and influenza surveillance using a joint Veterans Affairs and Department of Defense biosurveillance application
  105. A Comparison of Manual and Electronic Dengue Surveillance in Puerto Rico Veterans Affairs Facilities, 2010
  106. Correlation of Annual Precipitation with Dengue Infections in Puerto Rico Veterans Affairs Facilities, 2007-2010
  107. Development of a Standardized Process for Conducting Large-Scale Epidemiologic Lookback Investigations Following Improper Reprocessing of Reusable Medical Equipment
  108. Effective Detection of the 2009 H1N1 Influenza Pandemic in U.S. Veterans Affairs Medical Centers Using a National Electronic Biosurveillance System
  109. Cluster of necrotizing enterocolitis in a neonatal intensive care unit: New Mexico, 2007
  110. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States
  111. Enhanced Detection of Health Events through Biosurveillance in a Joint Veterans Affairs and Department of Defense Medical Center
  112. An Examination of Attitudes, Knowledge, and Clinical Practices Among Pennsylvania Pediatricians Regarding Breastfeeding and Smoking
  113. What Do Mothers Think About Concurrent Breast-Feeding and Smoking?
  114. CTNS Mutations in African American Patients with Cystinosis
  115. Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations
  116. Pulmonary Function and High-Resolution CT Findings in Patients With an Inherited Form of Pulmonary Fibrosis, Hermansky-Pudlak Syndrome, Due to Mutations in HPS-1
  117. Mutations of CTNS Causing Intermediate Cystinosis
  118. Breakpoint Identification, Detection and Frequency of the 65-kb Deletion in the Cystinosis Gene, CTNS
  119. Identification and Detection of the Common 65-kb Deletion Breakpoint in the Nephropathic Cystinosis Gene (CTNS)